Feng Shi

机构：Capital Medical University, United Imaging Healthcare (China), Shanghai Civil Aviation College, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Beijing Shijitan Hospital, Southern Medical University · ORCID：0000-0003-3509-3473

发表论文 67 篇 · 总被引 749 次 · h-index 16

代表论文

• HAIC plus lenvatinib and tislelizumab for advanced hepatocellular carcinoma with Vp4 portal vein invasion (2025 · Hepatology International · 被引 19)
• Automatic prediction of hepatic arterial infusion chemotherapy response in advanced hepatocellular carcinoma with deep learning radiomic nomogram (2023 · European Radiology · 被引 17)
• S-adenosylmethionine attenuates angiotensin II-induced aortic dissection formation by inhibiting vascular smooth muscle cell phenotypic switch and autophagy (2023 · Biochemical Pharmacology · 被引 15)
• AI-based tumor-infiltrating lymphocyte scoring system for assessing HCC prognosis in patients undergoing liver resection (2024 · JHEP Reports · 被引 13)
• Predicting pathological complete response following neoadjuvant chemoradiotherapy (nCRT) in patients with locally advanced rectal cancer using merged model integrating MRI-based radiomics and deep learning data (2024 · BMC Medical Imaging · 被引 13)
• TACE plus lenvatinib and tislelizumab for intermediate-stage hepatocellular carcinoma beyond up-to-11 criteria: a multicenter cohort study (2024 · Frontiers in Immunology · 被引 13)